secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0000950170-25-060317
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo files prospectus supplement to sell up to $3.17M in common stock via ATM
-------------------------------------------------------------------------------

- ATM offering of up to $3,167,548 in common stock under sales agreement with Roth Capital Partners.
- As of April 29, 2025, 305,845 shares sold at $0.5946/share for $181,848 gross proceeds.
- Supplement amends prior April 28, 2025 prospectus supplement; legal opinion filed as Exhibit 5.1.
- Shares offered under existing S-3 registration statement (File No. 333-284969).
- Paul Hastings LLP provided the legal opinion included in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025060317/0000950170-25-060317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025060317/apvo-20250429.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-060317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer